COVID-19 through the lens of a Ghanaian photographer
While the pandemic forced everyone else indoors, a Ghanaian photographer took to the streets to document Accra on lockdown.
“At last”: Ghanaian football star Michael Essien hails world’s first malaria vaccine
Years before Michael Essien began his extraordinary Premier League football career, he was a barefoot kid in small-town Ghana, scoring between goalposts made of stacked rocks. Like millions of other children in the world’s endemic zones, young…
Gavi Board approves funding to support malaria vaccine roll-out in sub-Saharan Africa
A new malaria vaccination programme will support Gavi-eligible countries to implement a new tool in the fight against malaria in sub-Saharan Africa in 2022-2025, including vaccine introduction, procurement and delivery
A Ghanaian doctor’s perspective on COVID-19 vaccine inequity
Pre-COVID-19, Ghana’s health system was overburdened. The virus has made everything harder, and vaccine inequity has made it harder still.
Discoveries from vaccine implementation
In episode 8 of the Global Health Matters podcast, we spoke to Professor Margaret Gyapong of the University of Health and Allied Sciences in Ghana and Dr Lee Hampton of Gavi, the Vaccine Alliance. These experts shared their views on how…
In Ghana, a strong cold chain makes all the difference
UNICEF and Gavi partnered to fund, procure and deliver more than 2,300 items of cold chain equipment to ensure health centres met immunization targets.
Bringing routine immunisation back into focus in Ghana
Community health nurses in Ghana are on a mission to reverse the decline in routine immunisation since the start of the COVID-19 pandemic.
Combining seasonal malaria vaccination with chemoprevention can cut malaria deaths in children by 70%
A new study suggests the RTS,S malaria vaccine alone is as effective as preventive antimalarials; together they could save thousands of lives.
Why Africa’s push to make vaccines should look further than COVID-19
Vaccine manufacturing doesn't come cheap. It depends heavily on support from developed countries. It also takes much more than relaxing intellectual property rights and a desire for vaccine equity.